FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2513176639> ?p ?o ?g. }

• W2513176639 endingPage "1115" @default.
• W2513176639 startingPage "1109" @default.
• W2513176639 abstract "To compare hospital length of stay (LOS) and hospital treatment costs in low-risk patients with pulmonary embolism (PE) anticoagulated with rivaroxaban or heparin bridging to warfarin therapy.Retrospective review of electronic health records and hospital billing records.Large, teaching hospital in the northeastern United States.One hundred ninety adults with objectively confirmed acute PE presenting to the emergency department between November 1, 2012, and May, 12, 2015, who were classified as low risk of early mortality and received anticoagulation with either rivaroxaban or heparin (i.e., unfractionated heparin or low-molecular-weight heparin) bridging to warfarin therapy were included in the analysis. Patients were identified as low risk by at least one of the following prediction rules: simplified Pulmonary Embolism Severity Index (sPESI; 115 patients), Hestia criteria (87 patients), or In-hospital Mortality for Pulmonary Embolism using Claims Data (IMPACT; 108 patients); these were not mutually exclusive, as patients could be classified as low risk by more than one risk stratification tool.We divided low-risk patients identified by each prediction rule into two cohorts: those receiving rivaroxaban (allowing ≤ 2 days of prior heparin use) or heparin bridging to warfarin therapy. The primary end points for this study were LOS (number of days from the patient's arrival at our institution until discharge) and total hospital treatment costs (our institution's actual costs to provide treatment) for the index PE hospital encounter. Using multivariable generalized linear model regression (gamma-distributed error and log-link), we estimated differences in LOS and hospital costs (in 2015 U.S. dollars) between the two cohorts after covariate adjustment. Rivaroxaban was associated with significantly shorter adjusted LOS (range -2.1 to -4.3 days) and significantly lower index hospital costs (range -$3835 to -$7094) versus heparin bridging to warfarin, regardless of the prediction rule used to identify low-risk patients.Among low-risk PE patients identified by using sPESI, Hestia or IMPACT, rivaroxaban was associated with significantly shorter LOS and lower hospital treatment costs versus heparin bridging to warfarin." @default.
• W2513176639 created "2016-09-16" @default.
• W2513176639 creator A5012212211 @default.
• W2513176639 creator A5032615520 @default.
• W2513176639 creator A5034742104 @default.
• W2513176639 creator A5040117870 @default.
• W2513176639 creator A5049367004 @default.
• W2513176639 creator A5075874365 @default.
• W2513176639 creator A5087850384 @default.
• W2513176639 date "2016-09-19" @default.
• W2513176639 modified "2023-10-05" @default.
• W2513176639 title "Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism" @default.
• W2513176639 cites W1638268966 @default.
• W2513176639 cites W1987269240 @default.
• W2513176639 cites W2023916064 @default.
• W2513176639 cites W2026341154 @default.
• W2513176639 cites W2045987573 @default.
• W2513176639 cites W2058810731 @default.
• W2513176639 cites W2120203545 @default.
• W2513176639 cites W2128617715 @default.
• W2513176639 cites W2139393300 @default.
• W2513176639 cites W2156917466 @default.
• W2513176639 cites W2162323452 @default.
• W2513176639 cites W2225937646 @default.
• W2513176639 doi "https://doi.org/10.1002/phar.1828" @default.
• W2513176639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27548074" @default.
• W2513176639 hasPublicationYear "2016" @default.
• W2513176639 type Work @default.
• W2513176639 sameAs 2513176639 @default.
• W2513176639 citedByCount "13" @default.
• W2513176639 countsByYear W25131766392016 @default.
• W2513176639 countsByYear W25131766392017 @default.
• W2513176639 countsByYear W25131766392018 @default.
• W2513176639 countsByYear W25131766392019 @default.
• W2513176639 countsByYear W25131766392020 @default.
• W2513176639 countsByYear W25131766392023 @default.
• W2513176639 crossrefType "journal-article" @default.
• W2513176639 hasAuthorship W2513176639A5012212211 @default.
• W2513176639 hasAuthorship W2513176639A5032615520 @default.
• W2513176639 hasAuthorship W2513176639A5034742104 @default.
• W2513176639 hasAuthorship W2513176639A5040117870 @default.
• W2513176639 hasAuthorship W2513176639A5049367004 @default.
• W2513176639 hasAuthorship W2513176639A5075874365 @default.
• W2513176639 hasAuthorship W2513176639A5087850384 @default.
• W2513176639 hasConcept C126322002 @default.
• W2513176639 hasConcept C167135981 @default.
• W2513176639 hasConcept C174348530 @default.
• W2513176639 hasConcept C177713679 @default.
• W2513176639 hasConcept C194828623 @default.
• W2513176639 hasConcept C195910791 @default.
• W2513176639 hasConcept C2776265017 @default.
• W2513176639 hasConcept C2776301958 @default.
• W2513176639 hasConcept C2776884760 @default.
• W2513176639 hasConcept C2777557582 @default.
• W2513176639 hasConcept C2778205648 @default.
• W2513176639 hasConcept C2778661090 @default.
• W2513176639 hasConcept C2779161974 @default.
• W2513176639 hasConcept C31258907 @default.
• W2513176639 hasConcept C41008148 @default.
• W2513176639 hasConcept C71924100 @default.
• W2513176639 hasConceptScore W2513176639C126322002 @default.
• W2513176639 hasConceptScore W2513176639C167135981 @default.
• W2513176639 hasConceptScore W2513176639C174348530 @default.
• W2513176639 hasConceptScore W2513176639C177713679 @default.
• W2513176639 hasConceptScore W2513176639C194828623 @default.
• W2513176639 hasConceptScore W2513176639C195910791 @default.
• W2513176639 hasConceptScore W2513176639C2776265017 @default.
• W2513176639 hasConceptScore W2513176639C2776301958 @default.
• W2513176639 hasConceptScore W2513176639C2776884760 @default.
• W2513176639 hasConceptScore W2513176639C2777557582 @default.
• W2513176639 hasConceptScore W2513176639C2778205648 @default.
• W2513176639 hasConceptScore W2513176639C2778661090 @default.
• W2513176639 hasConceptScore W2513176639C2779161974 @default.
• W2513176639 hasConceptScore W2513176639C31258907 @default.
• W2513176639 hasConceptScore W2513176639C41008148 @default.
• W2513176639 hasConceptScore W2513176639C71924100 @default.
• W2513176639 hasFunder F4320306257 @default.
• W2513176639 hasFunder F4320307765 @default.
• W2513176639 hasIssue "10" @default.
• W2513176639 hasLocation W25131766391 @default.
• W2513176639 hasLocation W25131766392 @default.
• W2513176639 hasOpenAccess W2513176639 @default.
• W2513176639 hasPrimaryLocation W25131766391 @default.
• W2513176639 hasRelatedWork W1866105834 @default.
• W2513176639 hasRelatedWork W2019616867 @default.
• W2513176639 hasRelatedWork W2085542854 @default.
• W2513176639 hasRelatedWork W2355421283 @default.
• W2513176639 hasRelatedWork W2426049967 @default.
• W2513176639 hasRelatedWork W2741766490 @default.
• W2513176639 hasRelatedWork W3031049035 @default.
• W2513176639 hasRelatedWork W3042480762 @default.
• W2513176639 hasRelatedWork W3179735828 @default.
• W2513176639 hasRelatedWork W4386104923 @default.
• W2513176639 hasVolume "36" @default.
• W2513176639 isParatext "false" @default.
• W2513176639 isRetracted "false" @default.
• W2513176639 magId "2513176639" @default.
• W2513176639 workType "article" @default.